Five projects at IRB Barcelona receive new funding from the Spanish Association Against Cancer. This support allows IRB Barcelona to advance in key research into metastasis and innovative drug develop...
Read moreA study led by the Institute for Neurosciences CSIC-UMH demonstrates that the brain reorganizes its sensory maps in the absence of tactile stimuli. These findings, published in Nature Communications, ...
Read moreThe discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age...
Read moreLa sobreexpresión de la proteína Bcl-xL en ratones mejora la función de los linfocitos T, reduce la inflamación y protege la integridad mitocondrial en los músculos, retrasando así la fragilidad...
Read moreAugustine Therapeutics, focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase 6 (HDAC6) enz...
Read moreLa suplementación con glutamato puede favorecer la regeneración hepática y beneficiar a pacientes en recuperación tras una hepatectomía o en espera de un trasplante, escriben los autores en Natur...
Read moreOn Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Cancer’. Funded by the Spanish Association Against C...
Read moreThe company develops innovative compounds that that RNA of cancer-driven genes. Its lead compound, currently advancing into the clinical phase, targets the treatment of malignant mesothelioma, a disea...
Read moreLas células de melanoma, el cáncer de piel más agresivo, producen una proteína que bloquea el reconocimiento y eliminación del tumor por parte del sistema inmunitario, las defensas naturales del ...
Read moreInvestigadores e investigadoras del Área de Enfermedades Hepáticas y Gastrointestinales del Instituto de Investigación Sanitaria Biogipuzkoa, han coordinado un estudio colaborativo internacional qu...
Read moreThe clinical-stage biotechnology company, Gain Therapeutics, has announced the administration of the first dose to a participant with Parkinson’s disease in its phase 1b clinical trial of GT-02287, ...
Read moreResearchers at IDIBAPS-Hospital Clínic and Hospital Universitario de Canarias have coordinated a study involving 57,000 people that compares the effectiveness of the two main strategies for screening...
Read more